A long-acting human growth hormone with delayed clearance (VRS-317): Results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults
Kevin C.J. Yuen, Gerard S. Conway, Vera Popovic, George R. Merriam, Timothy Bailey, Amir H. Hamrahian, Beverly M.K. Biller, Mark Kipnes, Jerome A. Moore, Eric Humphriss, George M. Bright, Jeffrey L. Cleland
Dive into the research topics of 'A long-acting human growth hormone with delayed clearance (VRS-317): Results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults'. Together they form a unique fingerprint.